SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001437749-21-002008
Filing Date
2021-02-04
Accepted
2021-02-04 16:16:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B2 atos20210203_424b2.htm 424B2 187613
2 atos20210203_424b2img001.jpg GRAPHIC 6066
  Complete submission text file 0001437749-21-002008.txt   197144
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-252335 | Film No.: 21591338
SIC: 2834 Pharmaceutical Preparations